Logo image of CCLDP

CARECLOUD INC - CCLD 8 3/4 PERP (CCLDP) Stock Fundamental Analysis

NASDAQ:CCLDP - Nasdaq - US14167R2094 - Currency: USD

19.43  -0.92 (-4.52%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CCLDP. CCLDP was compared to 36 industry peers in the Health Care Technology industry. The financial health of CCLDP is average, but there are quite some concerns on its profitability. CCLDP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CCLDP was profitable.
In the past year CCLDP had a positive cash flow from operations.
CCLDP had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CCLDP reported negative operating cash flow in multiple years.
CCLDP Yearly Net Income VS EBIT VS OCF VS FCFCCLDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

CCLDP's Return On Assets of -71.82% is on the low side compared to the rest of the industry. CCLDP is outperformed by 72.97% of its industry peers.
Looking at the Return On Equity, with a value of -109.17%, CCLDP is doing worse than 64.86% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.44%, CCLDP belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
Industry RankSector Rank
ROA -71.82%
ROE -109.17%
ROIC 8.44%
ROA(3y)-32.68%
ROA(5y)-25.49%
ROE(3y)-58.54%
ROE(5y)-43.02%
ROIC(3y)N/A
ROIC(5y)N/A
CCLDP Yearly ROA, ROE, ROICCCLDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

CCLDP's Operating Margin of 4.69% is amongst the best of the industry. CCLDP outperforms 81.08% of its industry peers.
Looking at the Gross Margin, with a value of 43.42%, CCLDP is doing worse than 64.86% of the companies in the same industry.
In the last couple of years the Gross Margin of CCLDP has remained more or less at the same level.
Industry RankSector Rank
OM 4.69%
PM (TTM) N/A
GM 43.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y0.66%
CCLDP Yearly Profit, Operating, Gross MarginsCCLDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CCLDP is destroying value.
There is no outstanding debt for CCLDP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CCLDP Yearly Shares OutstandingCCLDP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CCLDP Yearly Total Debt VS Total AssetsCCLDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

CCLDP has an Altman-Z score of 20.84. This indicates that CCLDP is financially healthy and has little risk of bankruptcy at the moment.
CCLDP has a Altman-Z score of 20.84. This is amongst the best in the industry. CCLDP outperforms 89.19% of its industry peers.
CCLDP has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
CCLDP has a better Debt to FCF ratio (0.05) than 86.49% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CCLDP is not too dependend on debt financing.
CCLDP's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. CCLDP outperforms 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 20.84
ROIC/WACC0.77
WACC10.9%
CCLDP Yearly LT Debt VS Equity VS FCFCCLDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

CCLDP has a Current Ratio of 1.03. This is a normal value and indicates that CCLDP is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.03, CCLDP is not doing good in the industry: 64.86% of the companies in the same industry are doing better.
A Quick Ratio of 1.01 indicates that CCLDP should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.01, CCLDP is doing worse than 64.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.01
CCLDP Yearly Current Assets VS Current LiabilitesCCLDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

2

3. Growth

3.1 Past

CCLDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.11%, which is quite impressive.
EPS 1Y (TTM)102.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.62%

3.2 Future

CCLDP is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -205.12% yearly.
CCLDP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.47% yearly.
EPS Next Y-800.4%
EPS Next 2Y-205.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.47%
Revenue Next 2Y2.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CCLDP Yearly Revenue VS EstimatesCCLDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2030 100M 200M 300M
CCLDP Yearly EPS VS EstimatesCCLDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 647.67 indicates a quite expensive valuation of CCLDP.
Based on the Price/Earnings ratio, CCLDP is valued a bit cheaper than 67.57% of the companies in the same industry.
When comparing the Price/Earnings ratio of CCLDP to the average of the S&P500 Index (26.32), we can say CCLDP is valued expensively.
The Forward Price/Earnings Ratio is negative for CCLDP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 647.67
Fwd PE N/A
CCLDP Price Earnings VS Forward Price EarningsCCLDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCLDP indicates a somewhat cheap valuation: CCLDP is cheaper than 70.27% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CCLDP is valued a bit cheaper than the industry average as 62.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 70.18
EV/EBITDA 39.87
CCLDP Per share dataCCLDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A cheap valuation may be justified as CCLDP's earnings are expected to decrease with -205.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-205.12%
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

CCLDP has a Yearly Dividend Yield of 3.54%.
Compared to an average industry Dividend Yield of 31.23, CCLDP pays a better dividend. On top of this CCLDP pays more dividend than 94.59% of the companies listed in the same industry.
CCLDP's Dividend Yield is a higher than the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 3.54%

5.2 History

On average, the dividend of CCLDP grows each year by 21.20%, which is quite nice.
CCLDP has been paying a dividend for at least 10 years, so it has a reliable track record.
CCLDP has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)21.2%
Div Incr Years0
Div Non Decr Years8
CCLDP Yearly Dividends per shareCCLDP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CCLDP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-5.14%
EPS Next 2Y-205.12%
EPS Next 3YN/A
CCLDP Yearly Income VS Free CF VS DividendCCLDP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

More info and screens

CARECLOUD INC - CCLD 8 3/4 PERP

NASDAQ:CCLDP (3/12/2025, 8:00:02 PM)

19.43

-0.92 (-4.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-13 2025-03-13/bmo
Earnings (Next)05-12 2025-05-12/bmo
Inst Owners11.24%
Inst Owner ChangeN/A
Ins Owners37.42%
Ins Owner ChangeN/A
Market Cap822.28M
Analysts82
Price Target31.59 (62.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.54%
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DP-5.14%
Div Incr Years0
Div Non Decr Years8
Ex-Date03-31 2025-03-31 (0.23)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-143.02%
Min EPS beat(2)-357.52%
Max EPS beat(2)71.48%
EPS beat(4)2
Avg EPS beat(4)-48.69%
Min EPS beat(4)-357.52%
Max EPS beat(4)93.25%
EPS beat(8)4
Avg EPS beat(8)-29.99%
EPS beat(12)8
Avg EPS beat(12)-3.98%
EPS beat(16)12
Avg EPS beat(16)0.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.94%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)-1.89%
Revenue beat(4)0
Avg Revenue beat(4)-3.98%
Min Revenue beat(4)-9.77%
Max Revenue beat(4)-1.89%
Revenue beat(8)0
Avg Revenue beat(8)-4.8%
Revenue beat(12)1
Avg Revenue beat(12)-3.54%
Revenue beat(16)3
Avg Revenue beat(16)-2.31%
PT rev (1m)-1.92%
PT rev (3m)20.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.2%
EPS NY rev (1m)0%
EPS NY rev (3m)8.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 647.67
Fwd PE N/A
P/S 7.41
P/FCF 70.18
P/OCF 42.93
P/B 17.68
P/tB 113.95
EV/EBITDA 39.87
EPS(TTM)0.03
EY0.15%
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)0.28
FCFY1.42%
OCF(TTM)0.45
OCFY2.33%
SpS2.62
BVpS1.1
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -71.82%
ROE -109.17%
ROCE 10.69%
ROIC 8.44%
ROICexc 8.95%
ROICexgc 61.55%
OM 4.69%
PM (TTM) N/A
GM 43.42%
FCFM 10.55%
ROA(3y)-32.68%
ROA(5y)-25.49%
ROE(3y)-58.54%
ROE(5y)-43.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y0.66%
F-Score6
Asset Turnover1.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0
Cap/Depr 48.43%
Cap/Sales 6.7%
Interest Coverage 5.55
Cash Conversion 93.12%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.01
Altman-Z 20.84
F-Score6
WACC10.9%
ROIC/WACC0.77
Cap/Depr(3y)85.6%
Cap/Depr(5y)83.34%
Cap/Sales(3y)8.65%
Cap/Sales(5y)7.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.71%
EPS Next Y-800.4%
EPS Next 2Y-205.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.62%
Revenue Next Year1.47%
Revenue Next 2Y2.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y349.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year612.5%
EBIT Next 3Y103.46%
EBIT Next 5YN/A
FCF growth 1Y33%
FCF growth 3YN/A
FCF growth 5Y-7.81%
OCF growth 1Y-9.74%
OCF growth 3YN/A
OCF growth 5Y17.82%